Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States
Total 18,500,000 5,910,000,000 2,360,000,000 256,000,000 149,000,000 283,000,000 8,950,000,000
• SOURCE Authors' analysis. NOTE All estimates are rounded to three significant figures.
• ↵a Measles total costs include $139,000 for epidemiological investigation cost.
• ↵b Because of the rare incidence of diphtheria among adults in the United States, no more than a single case is expected; therefore, the economic burden would not exceed the per person costs.
• ↵c Only the vaccine-preventable conditions of human papillomavirus (HPV) are included; oropharyngeal cancer, penile cancer, and recurrent respiratory papillomatosis are excluded.
